Abstract
Introduction: The coronavirus disease 2019 (COVID-19) pandemic is caused by the third known zoonotic coronavirus. It is a disease that does not spare any age group. The scientific community has been inundated with information since January. This review aims to summarise pertinent information related to COVID-19 in children.
Methods: A literature search was conducted in 2020 on the PubMed, MEDLINE, and Embase databases, with the keyword “COVID 19” and “children”. A bibliographic search of articles included was also undertaken. The abstracts were scanned to assess their appropriateness to be included in this narrative review. This was updated on the 11th April, 2020.
Results: The aetiology, transmission, incubation, pathophysiology, clinical features and complications, and management are discussed.
Conclusion: Our understanding of COVID-19 is evolving as more reports are published. The growth of SARS-CoV2 is limited in children and they are often asymptomatic. The disease course is also milder. Continued research to understand its effect on children is important to help us manage the disease in these vulnerable populations in a timely fashion.
Keywords: COVID-19, review, children, asymptomatic, pediatric, infants, neonates, SARS-CoV-2.
Current Pediatric Reviews
Title:COVID-19 in Children: A Narrative Review
Volume: 17 Issue: 3
Author(s): Jennifer F. Ha*
Affiliation:
- Department of Paediatrics Otolaryngology-Head & Neck Surgery, Perth Children’s Hospital, 15 Hospital Avenue, Nedlands 6009, Western Australia,Australia
Keywords: COVID-19, review, children, asymptomatic, pediatric, infants, neonates, SARS-CoV-2.
Abstract:
Introduction: The coronavirus disease 2019 (COVID-19) pandemic is caused by the third known zoonotic coronavirus. It is a disease that does not spare any age group. The scientific community has been inundated with information since January. This review aims to summarise pertinent information related to COVID-19 in children.
Methods: A literature search was conducted in 2020 on the PubMed, MEDLINE, and Embase databases, with the keyword “COVID 19” and “children”. A bibliographic search of articles included was also undertaken. The abstracts were scanned to assess their appropriateness to be included in this narrative review. This was updated on the 11th April, 2020.
Results: The aetiology, transmission, incubation, pathophysiology, clinical features and complications, and management are discussed.
Conclusion: Our understanding of COVID-19 is evolving as more reports are published. The growth of SARS-CoV2 is limited in children and they are often asymptomatic. The disease course is also milder. Continued research to understand its effect on children is important to help us manage the disease in these vulnerable populations in a timely fashion.
Export Options
About this article
Cite this article as:
Ha F. Jennifer *, COVID-19 in Children: A Narrative Review, Current Pediatric Reviews 2021; 17 (3) . https://dx.doi.org/10.2174/1573396317666210526155313
DOI https://dx.doi.org/10.2174/1573396317666210526155313 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Usefulness of Home Blood Pressure in the Diagnosis and Control of Hypertension in Primary Care
Current Hypertension Reviews Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews Diagnosis and Prognosis of Fetal Cardiomyopathies: A Review
Current Pharmaceutical Design Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Cardiovascular Comorbidities of COPD: When Do they Occur and How are they Managed?
Current Respiratory Medicine Reviews Chaperones and Cardiac Misfolding Protein Diseases
Current Protein & Peptide Science Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Sarcolemmal K<sub>ATP</sub> Channel Modulators and Cardiac Arrhythmias
Current Medicinal Chemistry Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Current Vascular Pharmacology Advances in Drug Safety
Current Pharmaceutical Design Atrial Tachycardias Occurring Late After Open Heart Surgery
Current Cardiology Reviews Cardiovascular Effects of Glucagon-Like Peptide 1
Mini-Reviews in Medicinal Chemistry Fish Pharming: Identifying Gene Function and Therapeutic Targets Using Pharmacologic Treatment of Zebrafish Embryos
Current Pharmacogenomics Disturbed Homeostasis in Patients with Acute Psychosis
Current Psychiatry Reviews Perioperative Considerations in Patients with Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Postoperative Delirium
Current Drug Targets A Review on Repurposed Drugs and Vaccine Trials for Combating SARS CoV-2
Current Drug Research Reviews The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists
Current Medicinal Chemistry Pharmacological Approach of No-Reflow Phenomenon Related with Percutaneous Coronary Interventions
Cardiovascular & Hematological Agents in Medicinal Chemistry Colloid Update
Current Pharmaceutical Design